Jennison Associates LLC acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 4th quarter, ...

Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Kura Oncology in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst ...

AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeuti BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE ...

Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...

Q3 2025 Earnings Call Transcript February 12, 2025 Aethlon Medical, Inc. beats earnings expectations. Reported EPS is $-0.13, ...

Here is how ANI Pharmaceuticals (ANIP) and CG Oncology, Inc. (CGON) have performed compared to their sector so far this year. The consensus price target hints at a 123.3% upside potential for CG ...

Q4 2024 Earnings Call Transcript February 11, 2025 Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.48 EPS, ...

What Happened: Morrow, Board Member at Lantheus Holdings, made a strategic move by exercising stock options for 0 shares of LNTH as detailed in a Form 4 filing on Wednesday with the U.S. Securities ...